Gilles Salles
Memorial Sloan Kettering Cancer Center
1015 Papers
4.9K Citations
Gilles Salles is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Medicine & Follicular lymphoma. The author has an hindex of 99, co-authored 854 publications. Previous affiliations of Gilles Salles include École normale supérieure de Lyon & Centre national de la recherche scientifique.
Chat about Author
Papers
•Journal Article
[The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas].
Przemyslaw Juszczynski,Ewa Kalinka,Grzegorz Woszczek,Maciej Borowiec,Tadeusz Robak,Marek L. Kowalski,Przemysław Biliński,Bertrand Coiffiers,Gilles Salles,Krzysztof Warzocha +9 more
TL;DR: The data indicate that innate immunity as reflected by the genetic propensity of the host to regulate TNF expression influences clinical course and outcome of NHL.
2
Abexinostat (S78454/PCI-24781), an Oral Pan-Histone Deacetylas (HDAC) Inhibitor in Patients with Refractory or Relapsed Hodgkin's Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia. Results of a Phase I Dose-Escalation Study in 35 Patients
Franck Morschhauser,Louis Terriou,Bertrand Coiffier,Gilles Salles,Ioana Kloos,Nicolas Tavernier,Stéphane Depil,Vincent Ribrag +7 more
TL;DR: The primary objective of the Phase I was to assess the safety profile and to determine the recommended Phase 2 dose (RP2D) as well as the optimal administration schedule of abexinostat in patients with refractory or relapsed lymphoma or chronic lymphocytic leukemia.
2
Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing
Ryan Ptashkin,Mark D. Ewalt,Gowtham Jayakumaran,Iwona Kiecka,Anita S. Bowman,J. Yao,Jacklyn Casanova,Y. T. Lin,Kseniya Petrova-Drus,Abhinita Mohanty,Ruben Bacares,Jamal Benhamida,Sharmila Rana,Anna Razumova,Chad M. Vanderbilt,A. B. Remav,Ivelise Rijo,J. Son-Garcia,Ino de Bruijn,M. Zhu,Sean K. Lachhander,W. Wang,Maryam S. Haque,Venkatraman E. Seshan,Jian Wang,Y S Liu,Khedoudja Nafa,Laetitia Borsu,Y. Zhang,Umut Aypar,Sarah P. Suehnholz,Debyani Chakravarty,J. H. Park,Omar Abdel-Wahab,Anthony R. Mato,W. Xiao,Mikhail Roshal,Mariko Yabe,Connie Lee Batlevi,Sergio Giralt,Gilles Salles,Raajit K. Rampal,Miranda M. Tallman,Eytan M. Stein,Ahmed I. Younes,Lev +45 more
TL;DR: The MSK-IMPACT Heme cohort is described, a comprehensive data set of somatic alterations from paired tumor and normal DNA using a hybridization capture-based next generation sequencing platform, and the power of appropriate matching to make definitive somatic calls is demonstrated, including in patients who have undergone allogeneic stem cell transplant.
•Journal Article
Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL)
Sylvain Choquet,Raoul Herbrecht,Gérard Socié,Anne-Marie Stoppa,Peter Vandenberghe,W Feremens,Anne-Marie Fischer,F Morschauser,Gilles Salles,Etienne Vilmer,Jeanne Luce Garnier,Arnaud Jaccard,T. Lamy,Peter Lang,Yvon Lebranchu,Fritz Offner,Eric Oksenhendler,K Imadalou,S Fafi,Anne-Sophie Moreau,Leblond,Noel-Jean Milpied +21 more
2